SK3 Group, Inc. (SKTO)

Market Cap	1.24K -98.5%
Revenue (ttm)	7.95M +42.9%
Net Income	22.20K
EPS	0.00
Shares Out	1.24B
PE Ratio	0.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	515,000
Average Volume	143,948
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	n/a
Beta	-24.91
RSI	48.16
Earnings Date	n/a

About SK3 Group

SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company was formerly known as CTT Interna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 17
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKTO

Financial Performance

In 2010, SK3 Group's revenue was $7.95 million, an increase of 42.92% compared to the previous year's $5.56 million. Earnings were $22,201, a decrease of -90.99%.